Changes In Health Services Use After Receipt Of Medications For Opioid Use Disorder In A Statewide Correctional System

被引:12
|
作者
Howell, Benjamin A. [1 ,2 ]
Martin, Rosemarie A. [3 ]
Lebeau, Rebecca [4 ]
Truong, Ashley Q. [5 ]
Wang, Emily A. [1 ]
Rich, Josiah D. [6 ,7 ]
Clarke, Jennifer G. [8 ]
机构
[1] Yale Sch Med, Sect Gen Internal Med, New Haven, CT 06510 USA
[2] Yale Sch Med, SEICHE Ctr, New Haven, CT 06510 USA
[3] Brown Univ, Sch Publ Hlth, Dept Behav & Social Sci, Providence, RI USA
[4] Rhode Isl Execut Off Hlth & Human Serv, Cranston, RI USA
[5] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mental Hlth, Baltimore, MD USA
[6] Brown Univ, Med & Epidemiol, Div Infect Dis, Providence, RI 02912 USA
[7] Miriam Hosp, Ctr Prisoner Hlth & Human Rights, Providence, RI 02906 USA
[8] Rhode Isl Dept Correct, Cranston, RI USA
关键词
ECONOMIC BURDEN; ASSISTED TREATMENT; UNITED-STATES; OVERDOSE; MORTALITY; RELEASE; COSTS; ABUSE; RISK;
D O I
10.1377/hlthaff.2020.02156
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
To decrease opioid overdose mortality, prisons and jails in the US are increasingly offering medications for opioid use disorder (OUD) to incarcerated people. It is unknown how receipt of these medications in a correctional setting affects health services use after release. In this article we analyze changes in postrelease health care use after the implementation of a statewide medications for OUD program in the unified jail and prison system of the Rhode Island Department of Corrections. Using Medicaid claims data, we examined individual health care use in the community before and after receipt of medications for OUD while incarcerated. We found that inpatient admissions did not change, emergency department visits decreased, and both nonacute outpatient services and pharmacy claims increased after people received medications for OUD while incarcerated. There was no change in total health care costs paid by Medicaid. Our findings provide evidence that people's use of health care services paid for by Medicaid did not increase after they started medications for OUD in correctional settings. Given the frequent interaction of people with OUD with the criminal justice system, offering evidence-based treatment of OUD in correctional settings is an important opportunity to initiate addiction treatment.
引用
收藏
页码:1304 / 1311
页数:8
相关论文
共 50 条
  • [21] Receipt of medications for opioid use disorder among youth engaged in primary care: data from 6 health systems
    Sarah M. Bagley
    Laura Chavez
    Jordan M. Braciszewski
    Mary Akolsile
    Denise M. Boudreau
    Gwen Lapham
    Cynthia I. Campbell
    Gavin Bart
    Bobbi Jo H. Yarborough
    Jeffrey H. Samet
    Andrew J. Saxon
    Rebecca C. Rossom
    Ingrid A. Binswanger
    Mark T. Murphy
    Joseph E. Glass
    Katharine A. Bradley
    Addiction Science & Clinical Practice, 16
  • [22] Brief video intervention to improve attitudes throughout medications for opioid use disorder in a correctional setting
    Lam, Jeffrey A.
    Lee, Hye In Sarah
    Truong, Ashley Q.
    Macmadu, Alexandria
    Clarke, Jennifer G.
    Rich, Josiah
    Brockmann, Brad
    JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2019, 104 : 28 - 33
  • [23] A Statewide Consultation Helpline for Rapid Linkage to Services for Youths With Opioid Use Disorder and Other Substance Use
    Adams, Zachary W.
    Smoker, Michael P.
    Marriott, Brigid R.
    Mermelstein, Sharon P.
    Ojo, Olawale
    Aalsma, Matthew C.
    Hulvershorn, Leslie A.
    Pediatrics, Partment of
    PSYCHIATRIC SERVICES, 2024, 75 (10) : 979 - 985
  • [24] Availability of Health Care Services and Medications for Opioid Use Disorder in Carceral Facilities in Washington, Oregon, and Idaho
    Neill-Gubitz, Hannah
    Graves, Janessa M.
    Barbosa-Leiker, Celestina
    JOURNAL OF HEALTH CARE FOR THE POOR AND UNDERSERVED, 2022, 33 (01) : 407 - 418
  • [25] Association of Receipt of Opioid Use Disorder-Related Telehealth Services and Medications for Opioid Use Disorder With Fatal Drug Overdoses Among Medicare Beneficiaries Before and During the COVID-19 Pandemic
    Jones, Christopher M.
    Shoff, Carla
    Blanco, Carlos
    Losby, Jan L.
    Ling, Shari M.
    Compton, Wilson M.
    JAMA PSYCHIATRY, 2023, 80 (05) : 508 - 514
  • [26] Associations Between Inpatient Induction on Medications for Opioid Use Disorder and Postdischarge Medications for Opioid Use Disorder Adherence, Overdose, and Service Use
    Noam, Krista R.
    Schmutte, Timothy J.
    Pirard, Sandrine
    Bourdon, Carol
    Langless, Daniel
    Plant, Robert
    JOURNAL OF ADDICTION MEDICINE, 2023, 17 (03) : E199 - E201
  • [27] Influences of the criminal justice system on use of medications for opioid use disorder: a qualitative study
    Emmeline Taylor
    Caroline Gray
    Matthew Stimmel
    Ingrid A. Binswanger
    Erica Morse
    Christine Timko
    Alex H. S. Harris
    David Smelson
    Andrea K. Finlay
    BMC Global and Public Health, 2 (1):
  • [28] Disparities in Access to Medications for Opioid Use Disorder in the Veterans Health Administration
    Finlay, Andrea K.
    Harris, Alex H. S.
    Timko, Christine
    Yu, Mengfei
    Smelson, David
    Stimmel, Matthew
    Binswanger, Ingrid A.
    JOURNAL OF ADDICTION MEDICINE, 2021, 15 (02) : 143 - 149
  • [29] Availability of Medications for Opioid Use Disorder in Community Mental Health Facilities
    Cantor, Jonathan
    Griffin, Beth Ann
    Levitan, Barbara
    Mendon-Plasek, Sapna J.
    Stein, Bradley D.
    Hunter, Sarah B.
    Ober, Allison J.
    JAMA NETWORK OPEN, 2024, 7 (06) : e2417545
  • [30] Disparities in Receipt of Medications for Opioid Use Disorder Before and During the COVID-19 Pandemic in the US Veterans Health Administration
    Sung, Minhee L.
    Leon, Casey
    Reisman, Joel I.
    Gordon, Kirsha S.
    Kerns, Robert D.
    Li, Wenjun
    Liu, Weisong
    Mitra, Avijit
    Yu, Hong
    Becker, William C.
    SUBSTANCE USE & ADDICTION JOURNAL, 2025, 46 (02): : 369 - 376